دورية أكاديمية
أعرض في EDS

New insights at the interface between leprosy and immune-mediated rheumatic diseases.

التفاصيل البيبلوغرافية
العنوان: New insights at the interface between leprosy and immune-mediated rheumatic diseases.
المؤلفون: Cruz VA; Federal University of Goiás, Goiás, Brazil., de Albuquerque CP; Department of Rheumatology, University of Brasilia, Brasilia, Brazil., Guimarães MFBR; Department of Rheumatology, Federal University of Minas Gerais, Belo Horizonte, Brazil., Dionello CDF; Department of Rheumatology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., Ribeiro SLE; Department of Rheumatology, Federal University of Amazonas, Manaus, Brazil., de Souza VA; Department of Rheumatology, Federal University of Juiz de Fora, Juiz de Fora, Brazil., Gomes CM; Department of Dermatology, University of Brasilia, Brasilia, Brazil., da Mota LMH; Department of Rheumatology, University of Brasilia, Brasilia, Brazil.
المصدر: Frontiers in medicine [Front Med (Lausanne)] 2023 Sep 25; Vol. 10, pp. 1239775. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Lausanne, Switzerland : Frontiers Media S.A., [2014]-
مستخلص: Leprosy is an infectious and contagious disease of slow evolution, triggered by Mycobacterium leprae . Arthritis is its third most common manifestation, after cutaneous and peripheral nerve involvement. Since musculoskeletal symptoms may be the initial presentation of the disease, it is important for health professionals to recognize its rheumatic manifestations for early diagnosis and appropriate treatment, especially in endemic areas. In addition, cases of leprosy have increased globally, notably in patients undergoing treatment with TNF-α blockers and due to the increase in migration and travel of people from developing countries to developed countries. This review proposes to discuss the main scenarios of mimicry of different rheumatic diseases by leprosy, as well as the role of immunosuppressive drugs used in rheumatology practice in the treatment of reactional states and in the risk of developing the infection.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2023 Cruz, Albuquerque, Guimarães, Dionello, Ribeiro, Souza, Gomes and Mota.)
References: Travel Med Infect Dis. 2020 Sep - Oct;37:101670. (PMID: 32302727)
Clin Infect Dis. 2011 Mar 1;52(5):e133-5. (PMID: 21292656)
PLoS Negl Trop Dis. 2008;2(11):e328. (PMID: 18982056)
Clin Microbiol Rev. 2006 Apr;19(2):338-81. (PMID: 16614253)
Clin Rheumatol. 2009 May;28(5):615-7. (PMID: 19259757)
Clin Infect Dis. 2007 Jul 1;45(1):e7-9. (PMID: 17554691)
Front Immunol. 2020 Apr 16;11:567. (PMID: 32373110)
Ann Rheum Dis. 2003 Nov;62(11):1106-11. (PMID: 14583576)
Indian J Dermatol. 2008;53(3):142-3. (PMID: 19882015)
Clin Chest Med. 2019 Dec;40(4):721-739. (PMID: 31731980)
Front Med (Lausanne). 2022 Jun 24;9:879527. (PMID: 35814767)
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):496-500. (PMID: 10727487)
Dermatol Pract Concept. 2019 Jul 31;9(3):222-224. (PMID: 31384501)
Clin Rheumatol. 2013 Oct;32(10):1557-63. (PMID: 23645094)
Lepr Rev. 2015 Dec;86(4):379-82. (PMID: 26964434)
Lancet. 1964 Nov 28;2(7370):1138-41. (PMID: 14213568)
Clin Rheumatol. 2022 May;41(5):1293-1304. (PMID: 35142903)
BMC Infect Dis. 2021 Apr 13;21(1):347. (PMID: 33849463)
PLoS Negl Trop Dis. 2017 Mar 30;11(3):e0005348. (PMID: 28358815)
An Bras Dermatol. 2013 Nov-Dec;88(6 Suppl 1):23-5. (PMID: 24346871)
Rheumatology (Oxford). 2022 Nov 2;61(11):e350-e351. (PMID: 35323918)
N Engl J Med. 2006 Aug 17;355(7):739. (PMID: 16914716)
J Neuroimmunol. 2000 Jun 1;105(1):64-8. (PMID: 10713365)
Ann Rheum Dis. 2012 Dec;71(12):2062-3. (PMID: 22730368)
Lepr Rev. 2008 Dec;79(4):372-86. (PMID: 19274984)
Cell Mol Immunol. 2017 Feb;14(2):146-179. (PMID: 27721455)
Case Reports Immunol. 2014;2014:641989. (PMID: 25580317)
Clin Infect Dis. 2006 Jul 15;43(2):e19-22. (PMID: 16779736)
Indian J Lepr. 2016 Apr;88(2):123-127. (PMID: 29757545)
Clin Rheumatol. 2009 Jan;28(1):79-84. (PMID: 18807102)
Int J Rheum Dis. 2013 Apr;16(2):129-33. (PMID: 23773635)
J Indian Med Assoc. 2008 Mar;106(3):165-6. (PMID: 18712135)
Rev Soc Bras Med Trop. 2019 Apr 11;52:e20180385. (PMID: 30994805)
Mem Inst Oswaldo Cruz. 2011 Aug;106(5):536-40. (PMID: 21894372)
Trans R Soc Trop Med Hyg. 2004 Oct;98(10):602-9. (PMID: 15289097)
Br J Rheumatol. 1998 Mar;37(3):270-3. (PMID: 9566666)
Arthritis Res Ther. 2011 Jul 13;13(4):229. (PMID: 21787439)
J Cutan Pathol. 2019 May;46(5):347-352. (PMID: 30666664)
J Rheumatol. 1998 Jan;25(1):111-9. (PMID: 9458213)
Int J Rheum Dis. 2016 Oct;19(10):1024-1031. (PMID: 26250118)
Int J Rheum Dis. 2016 Oct;19(10):1035-1038. (PMID: 27456320)
Rheumatology (Oxford). 2019 Jan 1;58(1):85. (PMID: 30020524)
Mol Biol Res Commun. 2020 Apr;9(1):17-22. (PMID: 32582789)
Am J Dermatopathol. 2008 Dec;30(6):555-60. (PMID: 19033928)
Front Med (Lausanne). 2023 Mar 13;10:1143402. (PMID: 36993802)
Front Med (Lausanne). 2022 Apr 25;9:870584. (PMID: 35547233)
Indian J Dermatol Venereol Leprol. 2022 May-Jun;88(4):464-477. (PMID: 34672479)
Rev Soc Bras Med Trop. 2011 Jan-Feb;44(1):85-90. (PMID: 21340415)
Chin Med J (Engl). 2020 Aug 20;133(16):2004-2006. (PMID: 32826472)
Acta Reumatol Port. 2011 Jan-Mar;36(1):30-7. (PMID: 21483278)
Acta Reumatol Port. 2011 Jan-Mar;36(1):61-4. (PMID: 21483282)
Lupus. 2015 Sep;24(10):1095-102. (PMID: 25761657)
Lepr Rev. 2006 Jun;77(2):121-9. (PMID: 16895068)
Int J Mycobacteriol. 2016 Jun;5(2):223-5. (PMID: 27242236)
J Trop Med. 2022 Jul 4;2022:8652062. (PMID: 35832335)
Ann Rheum Dis. 1990 Sep;49(9):715-7. (PMID: 2241289)
Front Immunol. 2018 Mar 09;9:463. (PMID: 29593724)
Semin Arthritis Rheum. 2012 Oct;42(2):127-30. (PMID: 22542278)
An Bras Dermatol. 2017 May-Jun;92(3):389-391. (PMID: 29186255)
J Pediatr (Rio J). 2014 Sep-Oct;90(5):457-63. (PMID: 24709568)
Am J Trop Med Hyg. 2020 May;102(5):1131-1136. (PMID: 32157993)
J Rheumatol. 1996 Jun;23(6):1020-1. (PMID: 8782134)
Am J Trop Med Hyg. 2020 Jun;102(6):1316-1318. (PMID: 32228782)
Indian J Dermatol. 2017 Nov-Dec;62(6):635-643. (PMID: 29263539)
Indian J Dermatol Venereol Leprol. 2004 Mar-Apr;70(2):76-8. (PMID: 17642569)
Int J Lepr Other Mycobact Dis. 1983 Mar;51(1):29-32. (PMID: 6683257)
Medicine (Baltimore). 1980 Nov;59(6):442-8. (PMID: 6969346)
Indian J Dermatol. 2012 Mar;57(2):114-7. (PMID: 22615507)
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):15-20. (PMID: 25651321)
Immunol Res. 2015 Feb;61(1-2):160-3. (PMID: 25412733)
BMJ Case Rep. 2022 Jul 21;15(7):. (PMID: 35863857)
J Neurol. 2015 Sep;262(9):2179-81. (PMID: 26233690)
PLoS Negl Trop Dis. 2017 Oct 13;11(10):e0006011. (PMID: 29028793)
Neuroimmunomodulation. 2022;29(1):15-20. (PMID: 34350891)
Clin Exp Immunol. 1987 Dec;70(3):529-37. (PMID: 3325202)
J Clin Rheumatol. 2011 Aug;17(5):269-71. (PMID: 21778902)
An Bras Dermatol. 2017 Jul-Aug;92(4):575-577. (PMID: 28954119)
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e21-e24. (PMID: 32564427)
Lepr Rev. 2016 Mar;87(1):118-21. (PMID: 27255067)
Rheumatology (Oxford). 2010 Dec;49(12):2237-42. (PMID: 20724432)
Rev Bras Reumatol Engl Ed. 2017 Nov - Dec;57(6):630-632. (PMID: 29173702)
Rev Bras Reumatol. 2010 May-Jun;50(3):333-9. (PMID: 21125169)
Lupus. 2000;9(8):594-600. (PMID: 11035434)
Adv Rheumatol. 2019 Nov 28;59(1):52. (PMID: 31779703)
Int J Lepr. 1963 Apr-Jun;31:178-82. (PMID: 14086702)
BMJ Case Rep. 2020 Jul 5;13(7):. (PMID: 32624492)
Springerplus. 2014 Dec 15;3:734. (PMID: 26034700)
Braz J Infect Dis. 2007 Jun;11(3):378-82. (PMID: 17684644)
Lepr Rev. 2004 Mar;75(1):50-6. (PMID: 15072126)
Brain Pathol. 2021 May;31(3):e12950. (PMID: 34043257)
Int J Lepr Other Mycobact Dis. 2005 Jun;73(2):127-8. (PMID: 16830656)
An Bras Dermatol. 2022 May-Jun;97(3):338-347. (PMID: 35379512)
فهرسة مساهمة: Keywords: Mycobacterium leprae; SLE; leprosy; rheumatic dieases; rheumatoid arthritis
تواريخ الأحداث: Date Created: 20231012 Latest Revision: 20231031
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10564075
DOI: 10.3389/fmed.2023.1239775
PMID: 37822467
قاعدة البيانات: MEDLINE
الوصف
تدمد:2296-858X
DOI:10.3389/fmed.2023.1239775